Ellen Lubman
About Ellen Lubman
Chief Business Officer Ellen Lubman
Ellen Lubman holds the position of Chief Business Officer. She has held this title in various companies, including Impel NeuroPharma, Inc. from October 2018 to July 2020. In this role, she has overseen key business operations and strategic initiatives to drive company growth and innovation.
Ellen Lubman's Education and Expertise
Ellen Lubman earned an M.B.A. from Stanford Graduate School of Business with a focus on Global Management, showcasing her strong foundation in business and strategic planning. She also holds a B.A. in Biology from Rutgers College, indicating a robust background in the sciences, which complements her business acumen.
Ellen Lubman's Professional Background
Ellen Lubman has extensive experience in leadership roles at various prominent companies. She has served as Vice President of External Science & Innovation at Forest Labs and continued in the same role at Actavis plc following its acquisition. Her leadership extends to positions at Kadmon Pharmaceuticals, Bristol Myers Squibb, Celtic Pharma Management, L.P., Robertson Stephens Investment Bank, and Abbott Labs.
Ellen Lubman's Advisory Roles and Board Memberships
Ellen Lubman serves on the Advisory Board of TMRW.org and is a member of the Scientific Advisory Board of the Daedalus Innovation Fund of Weill-Cornell. Additionally, she serves on the board of directors of Red Door Community of NYC (formerly Gilda’s Club of NYC), and is the Southern California Chairwoman of Executive Women in BIO.